We use cookies to deliver our online services. Details of the cookies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you agree to our use of cookies. To close this message click close.

Webinar | FDA's Regulation of Stem Cells and Regenerative Medicine in Light of Regenerative Sciences

Michael N. Druckman

Michael N. Druckman,

Washington, D.C.

Randy Prebula

Michael P. Levinson

21 March 2014
Hogan Lovells invites you to a 60-minute webinar on FDA's Regulation of Stem Cells and Regenerative Medicine in Light of Regenerative Sciences. The webinar will take place Tuesday, April 1, 2014 at 1:00 p.m. ET and will cover the following topics:

  • Can stem cell therapies still be considered within the practice of medicine and outside the realm of FDA oversight?
  • The implications of Regenerative Sciences with respect to pre- and post-market oversight.
  • The effect of growing demand for stem cell treatments and the risks of medical tourism to countries with inadequate regulatory oversight.
  • Development models: practical pathways from research to profitability.

The webinar will feature moderator Michael Druckman and speakers Michael Levinson, M.D., J.D. Randy Prebula, and the founder and executive director of the Genetics Policy Institute Bernard Siegel, who is also the founder and co-chair of the World Stem Cell Summit.

Update: Listen to the webinar here.

Michael N. Druckman

Michael N. Druckman,

Washington, D.C.

Randy Prebula

Michael P. Levinson

Loading data